Warning letter · FDA Warning Letters

Deggeh Foods, Inc.: FDA Warning Letter 628460 (Jul 29, 2022)

Agency action: Jul 29, 2022Record ID: fda_warning_-791995d33faad1f4
View official source ↗

What happened

Original notice title

Deggeh Foods, Inc. MARCS-CMS 628460, July 29, 2022

From the archived source record

Based on our inspection and subsequent review of product labeling collected during the inspection, your firm’s website at the Internet address [see original source] and your Facebook social media page at [see original source] category /Community/Deggeh-products-Natural-Organic-products-made-in-Gambia-564035160361406/, we have identified serious violations of the Federal Food, Drug, and Cosmetic Act (the Act) and applicable regulations. Unapproved New Drugs and Misbranded Drugs FDA reviewed your website at the Internet address [see original source] in June 2022 and has determined that you take orders there for your products Actibest® Health Plus Capsules, Best Hemorrhoids Rapid Action Herbal Healing Formula, StomachAID capsules, and Moringa Tea Bags. Food Poisoning Stomach Worms & Parasites” Best Hemorrhoids Rapid Action Herbal Healing Formula Product Label: “Best Hemorrhoids Rapid Action Herbal Healing Formula” Moringa Tea Bags Product Label: “Get almost instant results and relief for: MIGRAINS [sic], HIGHBLOOD [sic] PRESSURE, HIGH SUGAR, DIABETES, HIGH CHOLESTEROL . . . A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Actibest® Health Plus Capsules, StomachAID capsules, and Moringa Tea Bags fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)]. Adulterated Dietary Supplements The facility inspection revealed serious violations of the FDA’s regulations for Current Good Manufacturing Practice (CGMP) in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, under Title 21, Code of Federal Regulations (CFR), Part 111 (21 CFR Part 111).

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
No closeout listed in FDA table
Source checked
Jul 16, 2026
Record revision
547ee4c8d3c8

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Best Hemorrhoids Rapid Action Herbal Healing Formula; Goods Return Form; SUPPLEMENT FACTS; Serving Size – one tablespoon; 30 capsules; Serving size 2 Capsules; 25 Herbal Tea Bags; Actibest® Health Plus Capsules; StomachAID capsules; and Moringa Tea Bags; for distribution [72 Fed; and StomacAID Capsules; Moringa Tea Bags
Company
Deggeh Foods, Inc.
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.